M1824a Two Dose-Equivalent, 56-Days, Subcutaneous (s.c.), Glucagon-Like Peptide 2 (GLP-2) Regimens, 1.6 Mg Once Daily (OD) Versus 0.4 Mg Four Times Daily (QID), in the Treatment of Short Bowel Syndrome (SBS) Patients

✍ Scribed by Jeppesen, Palle B.; Gottschalck, Ida B.; Holst, Jens J.; Mortensen, Per B.

• Book ID: 122992104
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 137 KB
• Volume: 134
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(08)61996-4